Akers Biosciences signs US partner for POC (point-of-care) tests
This article was originally published in Clinica
Executive Summary
Akers Biosciences, the Thorofare, New Jersey firm that is listed on the UK's Alternative Investment Market (AIM), has signed a US distribution deal for its rapid diagnostic tests.